In our hands, an inverse association related osteocalcin and glucose metabolism, which could agree with the antagonizing effect of osteocalcin on hyperglycemia and β-cell dysfunction [59] and substantiate the converging effect of dysmetabolic changes of obesity with bone health. The gene discussed is BGLAP; the disease is Hyperglycemia.